|
spermatogenesis
|
GO:0007283 |
284 |
0.477
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.403
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.367
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.363
|
|
|
citrulline metabolic process
|
GO:0000052 |
3 |
0.348
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.319
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.309
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.297
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.264
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.250
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.250
|
|
|
regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity
|
GO:0031585 |
2 |
0.248
|
|
|
bone development
|
GO:0060348 |
120 |
0.247
|
|
|
regionalization
|
GO:0003002 |
337 |
0.237
|
Zebrafish |
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.223
|
|
|
gonad development
|
GO:0008406 |
141 |
0.216
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.213
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.211
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.211
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.199
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.194
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.187
|
Human |
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.180
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.177
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.173
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.170
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.164
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.152
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.147
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.145
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.140
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.138
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.135
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.134
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.132
|
|
|
gland development
|
GO:0048732 |
330 |
0.129
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.125
|
Human |
|
respiratory system development
|
GO:0060541 |
190 |
0.123
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.115
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.113
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.112
|
|
|
ossification
|
GO:0001503 |
216 |
0.112
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.110
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.110
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.109
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.108
|
|
|
lung development
|
GO:0030324 |
164 |
0.107
|
|
|
limb development
|
GO:0060173 |
166 |
0.107
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.106
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.104
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.103
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.100
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.100
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.100
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.098
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.098
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.098
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.097
|
Human |
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.096
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.095
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.094
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.094
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.092
|
|
|
tube formation
|
GO:0035148 |
140 |
0.090
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.090
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.089
|
Human |
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.089
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.086
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.084
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.084
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.082
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.082
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.081
|
Zebrafish |
|
olfactory learning
|
GO:0008355 |
2 |
0.080
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.080
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.079
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.075
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.074
|
|
|
tube closure
|
GO:0060606 |
91 |
0.074
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.074
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.072
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.071
|
|
|
retrograde vesicle mediated transport golgi to er
|
GO:0006890 |
1 |
0.071
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.071
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.071
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.070
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.070
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.070
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.069
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.068
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.068
|
Human |
|
protein acylation
|
GO:0043543 |
64 |
0.067
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.065
|
Human |
|
protein catabolic process
|
GO:0030163 |
221 |
0.064
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.064
|
|
|
renal system development
|
GO:0072001 |
225 |
0.063
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.063
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.063
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.062
|
|
|
kidney development
|
GO:0001822 |
213 |
0.062
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.061
|
Human |
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.061
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.061
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.061
|
|
|
cation transport
|
GO:0006812 |
399 |
0.060
|
Human |
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.059
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.058
|
|
|
histone modification
|
GO:0016570 |
159 |
0.057
|
Human |
|
cartilage development
|
GO:0051216 |
140 |
0.057
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.056
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.056
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.055
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.054
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.054
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.054
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.053
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.053
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.052
|
Human |
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.051
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.051
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.051
|
|
|
liver development
|
GO:0001889 |
66 |
0.051
|
|
|
cell division
|
GO:0051301 |
120 |
0.051
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.051
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.051
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.051
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.050
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.050
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.050
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.050
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.049
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.049
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.049
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.048
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.048
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.048
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.047
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.046
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.046
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.046
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.046
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.045
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.045
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.045
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.044
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.044
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.044
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.044
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
protein processing
|
GO:0016485 |
163 |
0.043
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.043
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.043
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.043
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.043
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.042
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.042
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.042
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.042
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.042
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.042
|
|
|
vesicle transport along microtubule
|
GO:0047496 |
9 |
0.041
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.041
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.041
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.041
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.041
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.040
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.040
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.040
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.040
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.039
|
Human |
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.039
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.039
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.039
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.039
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.038
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.038
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.038
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.038
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.038
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.038
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.038
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.037
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.037
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.037
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.037
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.037
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.037
|
Human |
|
amine metabolic process
|
GO:0009308 |
45 |
0.037
|
|
|
brain derived neurotrophic factor receptor signaling pathway
|
GO:0031547 |
3 |
0.037
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.037
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.037
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.037
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.037
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.037
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.036
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.036
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.036
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.036
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.036
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.036
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.035
|
|
|
cellularization
|
GO:0007349 |
1 |
0.035
|
|
|
rna interference
|
GO:0016246 |
2 |
0.035
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.035
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.035
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.034
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.034
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.034
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.034
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.034
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.034
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.034
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.034
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.034
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.033
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
Human |
|
organic anion transport
|
GO:0015711 |
137 |
0.033
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.033
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.033
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.033
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.033
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.033
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.032
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.032
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.032
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.032
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.032
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.032
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.032
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.032
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.031
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.031
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.031
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.031
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.030
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.030
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.030
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.030
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.030
|
|
|
negative regulation of synaptic vesicle transport
|
GO:1902804 |
3 |
0.030
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.030
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.030
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.029
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.029
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.029
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.029
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.029
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.029
|
|
|
anion transport
|
GO:0006820 |
177 |
0.029
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.028
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.028
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.028
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.028
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.028
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.027
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.027
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.027
|
|
|
negative regulation of synaptic vesicle exocytosis
|
GO:2000301 |
3 |
0.027
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.027
|
Zebrafish |
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.027
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.026
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.026
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.026
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.026
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.026
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.026
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.026
|
Human |
|
habituation
|
GO:0046959 |
3 |
0.026
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.026
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.026
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.026
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.026
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.026
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.026
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.026
|
Human |
|
cell aging
|
GO:0007569 |
35 |
0.026
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
Human |
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.025
|
|
|
associative learning
|
GO:0008306 |
61 |
0.025
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.025
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.025
|
Human |
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.025
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.025
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.025
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.025
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.025
|
|
|
organ growth
|
GO:0035265 |
117 |
0.025
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.025
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.025
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.025
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.025
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.025
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.025
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.025
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.025
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
Human |
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.025
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.024
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.024
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.024
|
|
|
neural plate development
|
GO:0001840 |
12 |
0.024
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.024
|
Human |
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.024
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.024
|
|
|
cell growth
|
GO:0016049 |
130 |
0.024
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.024
|
Human |
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.024
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.024
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.024
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.024
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.024
|
|
|
response to uv
|
GO:0009411 |
44 |
0.024
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.024
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.024
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.024
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.024
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.024
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.024
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.023
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.023
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.023
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.023
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.023
|
|
|
positive regulation of receptor activity
|
GO:2000273 |
17 |
0.023
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.023
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.023
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.023
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.023
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.023
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.023
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.023
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.022
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.022
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.022
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.022
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.022
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.022
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.022
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.022
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.022
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.022
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.022
|
|
|
male germ line stem cell asymmetric division
|
GO:0048133 |
2 |
0.022
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.022
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.022
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.021
|
Human |
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.021
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.021
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.021
|
|
|
dna repair
|
GO:0006281 |
107 |
0.021
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.021
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.021
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.021
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.021
|
Human |
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.021
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.021
|
Zebrafish |
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.021
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.021
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.021
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.021
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.021
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.021
|
Human |
|
pharynx development
|
GO:0060465 |
1 |
0.021
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.021
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.021
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.020
|
Human |
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.020
|
|
|
scf dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031146 |
10 |
0.020
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.020
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.020
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.020
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.020
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.020
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.020
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
appendage development
|
GO:0048736 |
166 |
0.020
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.020
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.020
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.020
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.020
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.020
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.020
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.020
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.019
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.019
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.019
|
|
|
regulation of membrane permeability
|
GO:0090559 |
18 |
0.019
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.019
|
|
|
regulation of transcription from rna polymerase i promoter
|
GO:0006356 |
6 |
0.019
|
|
|
learning
|
GO:0007612 |
98 |
0.019
|
|
|
regulation of mitochondrial membrane potential
|
GO:0051881 |
17 |
0.019
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.019
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.019
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.019
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.019
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.019
|
Zebrafish |
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.019
|
|
|
translation
|
GO:0006412 |
93 |
0.019
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.019
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.018
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.018
|
|
|
protein import
|
GO:0017038 |
101 |
0.018
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.018
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.018
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.018
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.018
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
regulation of phosphoprotein phosphatase activity
|
GO:0043666 |
3 |
0.018
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.018
|
Human |
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.018
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.018
|
Human |
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.018
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.018
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.018
|
|
|
amide transport
|
GO:0042886 |
138 |
0.018
|
Human |
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.018
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.018
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.018
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.018
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.018
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.018
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.018
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.018
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.018
|
|
|
methylation
|
GO:0032259 |
134 |
0.018
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.018
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.018
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.018
|
|
|
cognition
|
GO:0050890 |
149 |
0.018
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
Human |
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.017
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.017
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
intraspecies interaction between organisms
|
GO:0051703 |
21 |
0.017
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.017
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.017
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.017
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.017
|
Human |
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.017
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.017
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.017
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.017
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.017
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.017
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.017
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.017
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.017
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.017
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.017
|
Human |
|
regulation of histone modification
|
GO:0031056 |
56 |
0.017
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.017
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.016
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.016
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.016
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.016
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.016
|
|